Mens/Womens Health Flashcards
benefits of estrogen HT in menopause
decrease hip fx 25%
decrease vertebral fx 50%
decrease vaginal atrophy
decrease hot flashes
do not forget this if you do HT and have a uterus
also use a progesterone
risks of estrogen HT
gallbladder increases
increased risk of breast cancer - increases w/progesterone
endometrial cancer - lessens w/progesterone
heart disease
benefits of progesterone HT
decreases estrogen effects of irregular bleeding and hyperplasia and carcinoma
risks of progesterone HT
weight gain
irritability
depression - worse with higher doses
unpredictable bleeding w/continuous estrogen/progestin during first 8-12 months
when to use trandermal estrogen vs oral
if moderate risk of CHD and estrogen is needed
or does not tolerate oral well
vaginal estrogen for vasomotor symptoms
femring vaginal ring q3mo
estradiol acetate
estrogen/progesterone strategies
use progestin for 10-14 days and have a normal period
use continuous progestin, irregular bleeding, then amenorrhea
could do 3 days on and 3 days off but that’s rarely used any more
where do you apply the Divigel estrogen gel and the evamist estrogen spray?
gel - thighs
spray - forearm
progesterone primarily used in menopause for unopposed estrogen
medroxyprogesterone acetate
estrogen receptor agonist/antagonist for menopause sxs
ospemifene 60mg tabs (Osphena) - for vaginal atrophy
conjugated estrogens/bazedoxifene - prevent osteoporosis and mod to severe vasomotor symptoms - SERM
prasterone
vaginal atrophy
inactive steroid converted to androgen or estrogen
vaginal insert
caution in hx of breast cancer
definition of T scores in osteoporosis
-1 = 2x more likely to have a fracture
low bone mass and osteoporosis in relation to T score
-1 to -2.5 = low bone mass
>-2.5 = osteoporosis
low trauma spine or hip fx regardless of T score
low bone mass AND fragility fx or high FRAX score
drugs that increase risk of osteoporosis
SSRI’s
anticonvulsants, lithium
steroids
estrogen deficiency
excess levothyroxine
heparin
GNRH agonists
oncology
PPI’s
recommended daily Ca and Vit D intake
Calcium 1g
Vit D 1000 units
osteoporosis screening recommendations
women >70 and men >80 - Xrays of spine, hips, femoral neck
DXA scan or quantitative CT to measure T scores
may do younger women if T scores high or low trauma fractures or height loss significant
first line therapy for osteoporosis
bisphosphonates (except ibandronate - doesn’t help non-vertebral fx)
bisphosphonate side effects
GI - esophageal ulcer - don’t lie down 60 mins after
esophageal cancer
musculoskeletal pain
osteonecrosis of jaw
atypical fractures
duration of bisphosphonate therapy
treat orally for 5 years of IV for 3years and then reassess risk
may use for double this time frame if high risk of fractures
only bisphosphonate to show decreased mortality
zoledronic acid
bisphosphonate CrCl cut offs
CrCl <35 in alendronate and zoledronic acid
CrCl <30 in risedronate or ibandronate
RANKL inhibitors
denosumab - second line therapy for osteoporosis
SERMs
raloxifene 60mg daily
Duavee (conj. estrogen + bazedoxifene)